Your browser doesn't support javascript.
COVID-19 and gastroenteric manifestations.
Chen, Zhang-Ren; Liu, Jing; Liao, Zhi-Guo; Zhou, Jian; Peng, Hong-Wei; Gong, Fei; Hu, Jin-Fang; Zhou, Ying.
  • Chen ZR; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Liu J; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Liao ZG; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Zhou J; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Peng HW; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Gong F; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Hu JF; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China.
  • Zhou Y; Department of Pharmacy, The First Affiliated Hospital of Nanchang University, Nanchang 330100, Jiangxi Province, China. zyyiva@163.com.
World J Clin Cases ; 9(19): 4990-4997, 2021 Jul 06.
Article in English | MEDLINE | ID: covidwho-1314992
ABSTRACT
Coronavirus disease 2019 (COVID-19), caused by the infection of a novel coronavirus [severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)], has become a pandemic. The infection has resulted in about one hundred million COVID-19 cases and millions of deaths. Although SARS-CoV-2 mainly spreads through the air and impairs the function of the respiratory system, it also attacks the gastrointestinal epithelial cells through the same receptor, angiotensin converting enzyme 2 receptor, which results in gastroenteric symptoms and potential fecal-oral transmission. Besides the infection of SARS-CoV-2, the treatments of COVID-19 also contribute to the gastroenteric manifestations due to the adverse drug reactions of anti-COVID-19 drugs. In this review, we update the clinical features, basic studies, and clinical practices of COVID-19-associated gastroenteric manifestations.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: World J Clin Cases Year: 2021 Document Type: Article Affiliation country: Wjcc.v9.i19.4990

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study Language: English Journal: World J Clin Cases Year: 2021 Document Type: Article Affiliation country: Wjcc.v9.i19.4990